Insider · CIK 0001185955

ROUSSEAU FRANCK

Reports to the SEC for 2 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001185955

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2013-08-13	Ocera Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, Chief Medical & DEV Officer	AAward	+226K sh	—	—	226,000
2012-08-07	Ocera Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Director, Chief Medical & DEV Officer	AAward	+8,000 sh	—	—	8,000
2012-04-19	Ocera Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Director, Chief Medical & DEV Officer	AAward	+100K sh	—	—	100,000
2011-10-18	Ocera Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Director, Chief Medical & DEV Officer	AAward	+175K sh	—	—	175,000
2003-01-23	TRIANGLE PHARMACEUTICALS INCD Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−3,436 sh	$6.00	−$20.6K	6
2003-01-23	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−99K sh	—	—	—
2003-01-23	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−18.4K sh	—	—	—
2003-01-23	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−2,058 sh	—	—	—
2003-01-23	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−10K sh	—	—	—
2003-01-23	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−13K sh	—	—	—
2003-01-23	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−2,237 sh	—	—	—
2003-01-23	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−2,986 sh	—	—	—
2003-01-23	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−30K sh	—	—	—
2003-01-23	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−20K sh	—	—	—
2003-01-23	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−15K sh	—	—	—
2003-01-23	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−10K sh	—	—	—
2003-01-23	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−50K sh	—	—	—
2003-01-23	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−175K sh	—	—	—
2003-01-23	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−100K sh	—	—	—
2003-01-23	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−150K sh	—	—	—
2003-01-23	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)D Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−30K sh	—	—	—
2003-01-16	TRIANGLE PHARMACEUTICALS INCD Disposition to Issuer	Executive Vice President	DDisposition to Issuer	−14.3K sh	$6.00	−$85.9K	—
2003-01-10	TRIANGLE PHARMACEUTICALS INCM Exercise/Conversion	Executive Vice President	MExercise/Conversion	+9,999 sh	$2.55	+$25.5K	2.55
2003-01-10	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)M Exercise/Conversion	Executive Vice President	MExercise/Conversion	−9,999 sh	—	—	—
2002-09-20	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)A Award	Executive Vice President	AAward	+150K sh	—	—	—
2002-08-05	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)A Award	Executive Vice President	AAward	+100K sh	—	—	—
2002-02-27	TRIANGLE PHARMACEUTICALS INCStock Options (rights to buy)A Award	Executive Vice President	AAward	+175K sh	—	—	—

Recent filings

Accepted (ET)
Dec 234
Ocera Therapeutics, Inc.0001104659-13-091987
SEC(opens sec.gov)
Aug 94
ROUSSEAU FRANCK0001104659-12-056661
SEC(opens sec.gov)
Apr 234
ROUSSEAU FRANCK0001104659-12-027425
SEC(opens sec.gov)
Oct 214
ROUSSEAU FRANCK0001104659-11-057127
SEC(opens sec.gov)
Jan 274
ROUSSEAU FRANCK0001185955-03-000005
SEC(opens sec.gov)

Companies

Address

C/O TRANZYME, INC. 4819 EMPEROR BOULEVARD, SUITE 400

DURHAM, NC, 27703